These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37046317)

  • 1. The hypertension and hyperlipidemia status among type 2 diabetic patients in the community and influencing factors analysis of glycemic control.
    Zhai Z; Yang Y; Lin G; Lin W; Wu J; Liu X; Zhang S; Zhou Q; Liu H; Hao G
    Diabetol Metab Syndr; 2023 Apr; 15(1):73. PubMed ID: 37046317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the influencing factors and clinical related characteristics of pulmonary tuberculosis in patients with type 2 diabetes mellitus.
    Shi H; Yuan Y; Li X; Li YF; Fan L; Yang XM
    World J Diabetes; 2024 Feb; 15(2):196-208. PubMed ID: 38464376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of physical leisure time activities on glycaemic control in adult patients with diabetes type 2: A Systematic Review.
    Pai LW; Chang PY; Chen W; Hwu YJ; Lai CH
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-20. PubMed ID: 27820154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organisational and individual characteristics associated with glycaemic control among patients with type 2 diabetes: cross-sectional study in China.
    Wang H; Yao J; Yin X; Guo X; Yin J; Qu H; Sun Q
    BMJ Open; 2020 Apr; 10(4):e036331. PubMed ID: 32265251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycaemic control in type 2 diabetes patients and its predictors: a retrospective database study at a tertiary care diabetes centre in Ningbo, China.
    Li J; Chattopadhyay K; Xu M; Chen Y; Hu F; Chu J; Li L
    BMJ Open; 2018 Mar; 8(3):e019697. PubMed ID: 29581203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-peptide, glycaemic control, and diabetic complications in type 2 diabetes mellitus: A real-world study.
    Huang Y; Wang Y; Liu C; Zhou Y; Wang X; Cheng B; Kui C; Wang Y
    Diabetes Metab Res Rev; 2022 May; 38(4):e3514. PubMed ID: 34841643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of obesity is a risk factor for non-insulin-dependent diabetes mellitus, not for arterial hypertension or for hyperlipidaemia.
    Pontiroli AE; Galli L
    Acta Diabetol; 1998 Oct; 35(3):130-6. PubMed ID: 9840448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
    Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
    World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia.
    Alzaheb RA; Altemani AH
    Diabetes Metab Syndr Obes; 2018; 11():15-21. PubMed ID: 29430192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypomagnesemia and Poor Glycemic Control among Type 2 Diabetic Patients: A Cross-Sectional Study.
    Hamarshih M; Hamshari S; Nazzal Z; Snobar F; Mletat R; Abu-Mazen O; Maraqa B
    Indian J Endocrinol Metab; 2022; 26(6):575-580. PubMed ID: 39005513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for hyperlipidaemia in diabetes mellitus. Relationship to glycaemic control.
    Paterson JR; Pettigrew AR; Dominiczak MH; Small M
    Ann Clin Biochem; 1991 Jul; 28 ( Pt 4)():354-8. PubMed ID: 1892346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile and factors associated with glycaemic control of patients with type 2 diabetes in Greece: results from the diabetes registry.
    Souliotis K; Koutsovasilis A; Vatheia G; Golna C; Nikolaidi S; Hatziagelaki E; Kotsa K; Koufakis T; Melidonis A; Papazafiropoulou A; Tentolouris N; Siami E; Sotiropoulos A
    BMC Endocr Disord; 2020 Jan; 20(1):16. PubMed ID: 31992275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of macronutrients on glycaemic control: a systematic review of dietary randomised controlled trials in overweight and obese adults with type 2 diabetes in which there was no difference in weight loss between treatment groups.
    Emadian A; Andrews RC; England CY; Wallace V; Thompson JL
    Br J Nutr; 2015 Nov; 114(10):1656-66. PubMed ID: 26411958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between glycemic control and visceral adiposity index among the patients with type 2 diabetes mellitus].
    Cao YY; Tang X; Sun KX; Liu ZK; Xiang X; Juan J; Song J; Duan QZ; Zhaxi DJ; Hu YN; Yang YF; Shi MY; Tian YH; Huang SP; Liu XF; Li N; Li J; Wu T; Chen DF; Hu YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 49(3):446-450. PubMed ID: 28628145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of blood pressure and blood glucose control in patients with co-morbid hypertension and type 2 diabetes mellitus in Ghana: A hospital-based cross-sectional study.
    Alhassan Y; Kwakye AO; Dwomoh AK; Baah-Nyarkoh E; Ganu VJ; Appiah B; Kretchy IA
    PLOS Glob Public Health; 2022; 2(12):e0001342. PubMed ID: 36962917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-to-onset of treatment for hypertension and hyperlipidaemia in South African diabetes mellitus patients: A survival analysis using medicine claims data.
    Obeng-Kusi M; Lubbe MS; Cockeran M; Burger JR
    J Clin Pharm Ther; 2019 Oct; 44(5):701-707. PubMed ID: 31074041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of periodontal disease for glycaemic control in people with diabetes mellitus.
    Simpson TC; Weldon JC; Worthington HV; Needleman I; Wild SH; Moles DR; Stevenson B; Furness S; Iheozor-Ejiofor Z
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004714. PubMed ID: 26545069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship Between Glycaemic Control and Non-Alcoholic Fatty Liver Disease in Nigerian Type 2 Diabetic Patients.
    Afolabi BI; Ibitoye BO; Ikem RT; Omisore AD; Idowu BM; Soyoye DO
    J Natl Med Assoc; 2018 Jun; 110(3):256-264. PubMed ID: 29778128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study.
    Kautzky-Willer A; Stich K; Hintersteiner J; Kautzky A; Kamyar MR; Saukel J; Johnson J; Lemmens-Gruber R
    Cardiovasc Diabetol; 2013 May; 12():78. PubMed ID: 23705959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.